MedTrace Logo

Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer

NCT06671613 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-11-10

No results posted yet for this study

Summary

The purpose of this study is to learn the effects of fasting on cancer cells while you get maintenance treatment.

Conditions

  • Stage IV NSCLC
  • NSCLC
  • Immunotherapy
  • Fasting Mimicking Diet

Interventions

DIETARY_SUPPLEMENT

FMD

Plant-based diet program

COMBINATION_PRODUCT

Regular Diet Plus FMD

Patients will eat a RD with the first 3 cycles, then receive 3 cycles of FMD as they continue cycles 4-6

Sponsors & Collaborators

  • Indiana University

    collaborator OTHER

  • US Department of Veterans Affairs Cooperative Studies Program

    collaborator NETWORK

  • L-Nutra Inc

    collaborator INDUSTRY

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Shadia Jalal, MD · Richard L. Roudebush VA Medical Center, Indianapolis, IN

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-27
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06671613 on ClinicalTrials.gov